Back to VANGUARD GROUP INC

AVTX
6 quarters

Position history for VANGUARD GROUP INC's holdings in AVALO THERAPEUTICS INC

VANGUARD GROUP INC holds 804,084 shares of AVTX (AVALO THERAPEUTICS INC), worth $14.6M as of 2025-Q4. The position was increased (+16.1% shares). AVTX represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$14.6M

Current Shares

804,084

Total Value Change

+$14.5M

Total Shares Change

+793,716

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
804,084
+16.1%
$14.6M0.0%$17.81
32
2025-Q3
Increased
692,637
+314.9%
$8.8M0.0%$13.02
44
2025-Q2
Unchanged
166,941
0.0%
$833,0360.0%$4.78
0
2025-Q1
Increased
166,941
+0.7%
$1.3M0.0%$8.46
17
2024-Q4
Increased
165,801
+1499.2%
$1.2M0.0%$7.80
28
2024-Q3
New
10,368
-
$98,0810.0%$9.40
33

Other major holders of AVTX: FMR LLC, Avoro Capital Advisors LLC, UBS Group AG, Point72 Asset Management, L.P., FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used